MultipleMyeloma,myeloma,NDMM,MedNews,MedEd

Mashup Score: 4

Efficacy of Isa-VRd as first-line therapy in newly diagnosed MM - 2 day(s) ago

We summarize results from a phase III trial evaluating the safety and efficacy of Isa-VRd vs VRd in adult patients with newly diagnosed MM who were eligible for transplantation.

Source: multiplemyelomahub.com

Categories: General Medicine News, Oncologists1

Tweet Tweets with this article
- MM_Hub
  
  New publication 📝 Results from a phase III trial of Isa-VRd in newly diagnosed MM published by Facon et al. in @NEJM show that Isa-VRd was more effective as first-line therapy than VRd. Learn more: https://t.co/xKNzwCOwQl #MultipleMyeloma #myeloma #NDMM #MedNews #MedEd https://t.co/zO5UmuKLjk